|
|
|
 NEWS |
|
|
Control Medical Earns New Patent from the U.S. Patent and Trademark Office
August 18, 2011
Park City, Utah-- The U.S. Patent and Trademark Office awarded Control Medical Technology patent #7,976,511 on the ASPIRE Aspiration System. This new patent increases Control Medical’s patent portfolio to (4) four issued patents and (7) seven pending U.S. and global patents.
"We are excited to earn new patent protection for the ASPIRE Aspiration System," said Shawn Fojtik, Control's Chief Executive Officer. "Each time we show the system to clinicians, we learn of new procedures where the ASPIRE Aspiration System can improve patient care. We look forward to filling needs with a safe, efficient, and cost-effective system."
The ASPIRE Aspiration System includes devices under development for thrombus (blood clot) aspiration, tissue resection, biopsy, and general fluid aspiration. The ASPIRE Aspirator, core to the Aspiration System, is FDA cleared to aspirate fluids. Control’s MAX Aspiration Catheters are not FDA cleared or for sale at this time.
Control Medical is developing a family of Aspirator devices for aspiration, thrombus extraction, biopsy, and other applications where fluids are aspirated through small devices to diagnose, treat, or enable other medical devices. Control Medical Technology is headquartered in Park City, Utah USA, www.ASPIRATIONMEDICAL.com. |
| |
Control Medical Earns New Patent from the U.S. Patent and Trademark Office
March 19, 2010
Park City, Utah-- Control Medical Technology announced it received a new patent #7,674,247 from the U.S. Patent and Trademark Office on the Double Barrel Aspirator. The company also confirmed the Double Barrel Aspirator is registered with the European Union's Office for Harmonization in the Internal Market Trade Marks and Design (OHIM). Control now has three issued and numerous other pending U.S. and global patents.
Control's Double Barrel Aspirator's design hinges the front and rear handles directly to the Double Barrel Plunger and Barrels. Squeezing the handles pushes one plunger in to inject while it simultaneously pulls the other plunger out. The Double Barrel may also be configured with automatic one-way valves to supply the injection barrel or drain the aspiration barrel.
"The Double Barrel Aspirator is promising technology to serve a number of clinical needs," said Shawn Fojtik, Control's Chief Executive Officer. "The technology may power internal injection catheters, needles, tubes, or trocars for improved aspiration and/or be configured for surgical lavage, sinus lavage, and other procedures where injection and aspiration are required."
Disposable syringes are used worldwide in millions of procedures per year to assist in blood clot removal; biopsy; drainage of abscesses, cysts, and plural effusions; and other procedures. The Aspirator platform is open ended with universal connectors in a variety of barrel sizes that are compatible with multiple catheters, needles, and related medical devices.
Control Medical is developing a family of Aspirator devices for aspiration, thrombus extraction, biopsy, and other applications where fluids are aspirated through small devices to diagnose, treat, or enable other medical devices. Control Medical Technology is headquartered in Park City, Utah USA, www.aspirationmedical.com, www.maspirator.com and www.maxpirator.com. |
| | TOP | |
New Cost-Effective Medical Device Improves Fluid Aspiration
August 18, 2009
Park City, Utah-- Control Medical Technology, LLC announced a new cost-effective medical device to improve fluid aspiration from the body.
The Maspirator™ is a catheter accessory and manual surgical instruments that reduces the viscosity of tissue, pathology, and other fluids inside a catheter to improve aspiration.
A disposable Maspirator may be connected to an ASPIRE Aspiration Device or ordinary syringes. Maspirator technology is manually actuated by the physician's hand to facilitate tactile feel and control of the device.
"The Maspirator is a cost-effective hand-actuated device to improve aspiration effectiveness and control," said Shawn Fojtik, Control Medical Technology's Chief Executive Officer. "This technology will allow clinicians to control maceration and aspiration of fluids, tissues, and pathology inside a catheter. This technology is another example of our commitment to improve patient care and aspiration performance for a number of procedures."
Control Medical Technology secured the web site domains and will show the technology to physician advisers in 2009 at the Trans Catheter Therapeutics meeting. Control Medical is headquartered in Park City, Utah USA, www.aspirationmedical.com, www.maspirator.com and www.maxpirator.com. |
| | TOP | |
Control Medical Closes Series A Financing with Strategic Investors
May 14, 2009
Control Medical Technology, LLC announced the closing of a Series A financing with a team of medical device manufacturers, global distributors, and investors. Spring Bay Ventures, a medical-technology focused investor based in Jacksonville, Florida, led the funding.
“We are excited about the opportunity to invest in Control Medical Technology, led by Shawn Fojtik,” said Daniel Ryan, Vice President of Spring Bay Ventures. “Shawn is a terrific innovator with a proven ability to turn his ideas into businesses that meet clinical needs.” Mr. Ryan will be joining the Board of Directors of Control Medical Technology.
Control Medical’s ASPIRE aspiration platform under development may be used to remove fluids, tissue, thrombus (blood clots), and other pathology for use in cardiovascular, oncology, spine, pain management, wound irrigation/lavage, and general procedures.
According to the company, ASPIRE biopsy systems may be the first cost-effective 100% disposable rotational vacuum-assisted technology for breast biopsy. Rotational vacuum-assisted technologies spin a needle, catheter, or trocar with vacuum aspiration force to ‘cut and core’ tissue for improved biopsy quality and diagnostic confidence.
In addition, the ASPIRE platform can be modified to perform prostate and general biopsy; spinal disc decompression; bone marrow extraction (autologous stem cell harvesting); and other procedures.
“Rotational vacuum-assisted biopsy technologies improve breast biopsy diagnostics, but typically require expensive capital equipment and consumables limiting patient access,” said Shawn Fojtik, CEO of Control Medical. “The ASPIRE system does not require new capital equipment and gives the clinician control/tactile feel for the procedure.”
Control Medical is also planning to expand the ASPIRE platform into thrombus aspiration for heart attack, stroke, and hemodialysis access.
“There are global unmet needs for simplified thrombus aspiration systems,” commented Mr. Fojtik. “ASPIRE rotational and non-rotational thrombus aspiration catheters and systems under development include innovations for use in acute myocardial infarction, ischemic stroke, and hemodialysis grafts.”
Control Medical Technology’s team recently led Pinyon Medical Technology. Within 28-months of funding, Pinyons earned one U.S. patent, added four new patent applications, obtained two FDA 510(k) approvals, won a global 2008 Medical Design Excellence Award (MDEA), and then sold to Covidien.
The ASPIRE Aspirator is FDA 510(k) cleared but not for sale at this time. Roberts Mitani, LLC (www.robertsmitani.com) advised Control Medical in connection with this financing. Control Medical is headquartered in Park City, Utah with global sales offices in Florida www.ASPIRATIONMEDICAL.com. |
| | TOP | |
|
|
